Article info

Download PDFPDF
Original research
Therapeutic potential of FLANC, a novel primate-specific long non-coding RNA in colorectal cancer

Authors

  • Martin Pichler Department of Experimental Therapeutics, University of Texas MD Anderson Cancer Center, Houston, Texas, USADivision of Oncology, Medical University of Graz, Graz, Styria, Austria PubMed articlesGoogle scholar articles
  • Cristian Rodriguez-Aguayo Department of Experimental Therapeutics, University of Texas MD Anderson Cancer Center, Houston, Texas, USACenter for RNA interference and Non-coding RNA, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA PubMed articlesGoogle scholar articles
  • Su Youn Nam Department of Experimental Therapeutics, University of Texas MD Anderson Cancer Center, Houston, Texas, USAGastroenterology Department, Kyungpook National University Hospital; School of Medicine, Kyungpook National University, Daegu, South Korea PubMed articlesGoogle scholar articles
  • Mihnea Paul Dragomir Department of Experimental Therapeutics, University of Texas MD Anderson Cancer Center, Houston, Texas, USA PubMed articlesGoogle scholar articles
  • Recep Bayraktar Department of Experimental Therapeutics, University of Texas MD Anderson Cancer Center, Houston, Texas, USA PubMed articlesGoogle scholar articles
  • Simone Anfossi Department of Experimental Therapeutics, University of Texas MD Anderson Cancer Center, Houston, Texas, USA PubMed articlesGoogle scholar articles
  • Erik Knutsen Department of Experimental Therapeutics, University of Texas MD Anderson Cancer Center, Houston, Texas, USADepartment of Medical Biology, Faculty of Health Sciences, UiT - The Arctic University of Norway, Tromsø, Norway PubMed articlesGoogle scholar articles
  • Cristina Ivan Department of Experimental Therapeutics, University of Texas MD Anderson Cancer Center, Houston, Texas, USACenter for RNA interference and Non-coding RNA, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA PubMed articlesGoogle scholar articles
  • Enrique Fuentes-Mattei Department of Experimental Therapeutics, University of Texas MD Anderson Cancer Center, Houston, Texas, USA PubMed articlesGoogle scholar articles
  • Sang Kil Lee Department of Experimental Therapeutics, University of Texas MD Anderson Cancer Center, Houston, Texas, USADepartment of Internal Medicine, Institute of Gastroenterology, Yonsei University College of Medicine, Seoul, South Korea PubMed articlesGoogle scholar articles
  • Hui Ling Department of Experimental Therapeutics, University of Texas MD Anderson Cancer Center, Houston, Texas, USA PubMed articlesGoogle scholar articles
  • Tina Catela Ivkovic Department of Experimental Therapeutics, University of Texas MD Anderson Cancer Center, Houston, Texas, USADivision of Molecular Medicine, Ruder Boskovic Institute, Zagreb, Croatia PubMed articlesGoogle scholar articles
  • Guoliang Huang Department of Experimental Therapeutics, University of Texas MD Anderson Cancer Center, Houston, Texas, USAChina-America Cancer Research Institute, Dongguan Scientific Research Center, Guangdong Medical University, Dongguan, China PubMed articlesGoogle scholar articles
  • Li Huang Department of Cancer Biology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA PubMed articlesGoogle scholar articles
  • Yoshinaga Okugawa Center for Gastrointestinal Research and Center for Translational Genomics and Oncology, Baylor Scott and White Health Research Institute and Charles A. Sammons Cancer Center, Baylor University Medical Center, Dallas, Texas, USA PubMed articlesGoogle scholar articles
  • Hiroyuki Katayama Department of Clinical Cancer Prevention, University of Texas MD Anderson Cancer Center, Houston, Texas, USA PubMed articlesGoogle scholar articles
  • Ayumu Taguchi Department of Clinical Cancer Prevention, University of Texas MD Anderson Cancer Center, Houston, Texas, USA PubMed articlesGoogle scholar articles
  • Emine Bayraktar Department of Experimental Therapeutics, University of Texas MD Anderson Cancer Center, Houston, Texas, USA PubMed articlesGoogle scholar articles
  • Rajat Bhattacharya Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA PubMed articlesGoogle scholar articles
  • Paola Amero Department of Experimental Therapeutics, University of Texas MD Anderson Cancer Center, Houston, Texas, USA PubMed articlesGoogle scholar articles
  • William Ruixian He Department of Experimental Therapeutics, University of Texas MD Anderson Cancer Center, Houston, Texas, USA PubMed articlesGoogle scholar articles
  • Anh M Tran Department of Experimental Therapeutics, University of Texas MD Anderson Cancer Center, Houston, Texas, USA PubMed articlesGoogle scholar articles
  • Petra Vychytilova-Faltejskova Central European Institute of Technology, Masaryk University, Brno, Czech RepublicDepartment of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute, Brno, Czech Republic PubMed articlesGoogle scholar articles
  • Christiane Klec Division of Oncology, Medical University of Graz, Graz, Styria, Austria PubMed articlesGoogle scholar articles
  • Diana L Bonilla Department of Stem Cell Transplantation, University of Texas MD Anderson Cancer Center, Houston, Texas, USA PubMed articlesGoogle scholar articles
  • Xinna Zhang Center for RNA interference and Non-coding RNA, The University of Texas MD Anderson Cancer Center, Houston, Texas, USAMedical and Molecular Genetics Department, Indiana University, Indianapolis, Indiana, USA PubMed articlesGoogle scholar articles
  • Sanja Kapitanovic Division of Molecular Medicine, Ruder Boskovic Institute, Zagreb, Croatia PubMed articlesGoogle scholar articles
  • Bozo Loncar Department of Surgery, Dubrava Clinical Hospital, Zagreb, Croatia PubMed articlesGoogle scholar articles
  • Roberta Gafà Department of Morphology, Surgery and Experimental Medicine, University of Ferrara, Ferrara, Emilia-Romagna, Italy PubMed articlesGoogle scholar articles
  • Zhihui Wang Mathematics in Medicine Program, The Houston Methodist Research Institute, Houston, Texas, USA PubMed articlesGoogle scholar articles
  • Vittorio Cristini Mathematics in Medicine Program, The Houston Methodist Research Institute, Houston, Texas, USA PubMed articlesGoogle scholar articles
  • Samir M Hanash Department of Clinical Cancer Prevention, University of Texas MD Anderson Cancer Center, Houston, Texas, USA PubMed articlesGoogle scholar articles
  • Menashe Bar-Eli Department of Cancer Biology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA PubMed articlesGoogle scholar articles
  • Giovanni Lanza Department of Medical Sciences, University of Ferrara, Ferrara, Emilia-Romagna, Italy PubMed articlesGoogle scholar articles
  • Ondrej Slaby Central European Institute of Technology, Masaryk University, Brno, Czech RepublicDepartment of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute, Brno, Czech Republic PubMed articlesGoogle scholar articles
  • Ajay Goel Center for Gastrointestinal Research and Center for Translational Genomics and Oncology, Baylor Scott and White Health Research Institute and Charles A. Sammons Cancer Center, Baylor University Medical Center, Dallas, Texas, USADepartment of Molecular Diagnostics, Therapeutics and Translational Oncology, City of Hope National Medical Center, Duarte, California, USA PubMed articlesGoogle scholar articles
  • Isidore Rigoutsos Computational Medicine Center and Department of Pathology, Anatomy and Cell Biology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA PubMed articlesGoogle scholar articles
  • Gabriel Lopez-Berestein Department of Experimental Therapeutics, University of Texas MD Anderson Cancer Center, Houston, Texas, USACenter for RNA interference and Non-coding RNA, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA PubMed articlesGoogle scholar articles
  • George Adrian Calin Department of Experimental Therapeutics, University of Texas MD Anderson Cancer Center, Houston, Texas, USACenter for RNA interference and Non-coding RNA, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA PubMed articlesGoogle scholar articles
  1. Correspondence to Dr George Adrian Calin, Experimental Therapeutics, University of Texas MD Anderson Cancer Center, Houston, Texas, USA; gcalin{at}mdanderson.org; Dr Gabriel Lopez-Berestein, Experimental Therapeutics, University of Texas MD Anderson Cancer Center, Houston, Texas, USA; glopez{at}mdanderson.org
View Full Text

Citation

Pichler M, Rodriguez-Aguayo C, Nam SY, et al
Therapeutic potential of FLANC, a novel primate-specific long non-coding RNA in colorectal cancer

Publication history

  • Received April 16, 2019
  • Revised November 21, 2019
  • Accepted December 24, 2019
  • First published January 27, 2020.
Online issue publication 
September 07, 2020

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.